Financial Snapshot

Revenue
$0.00
TTM
Gross Margin
Net Earnings
-$5.147M
TTM
Current Assets
Q4 2024
Current Liabilities
Q4 2024
Current Ratio
109.04%
Q4 2024
Total Assets
Q4 2024
Total Liabilities
Book Value
Cash
Q4 2024
P/E
-1.533
Nov 29, 2024 EST
Free Cash Flow

Revenues

Revenues

Revenue YoY Change

Revenues

Concept 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008
Revenue $0.00 $0.00 $0.00 $328.8K $410.0K $211.8K $228.3K $1.272M $758.7K $372.1K $545.5K $290.0K $700.0K $850.0K $0.00 $0.00
YoY Change -100.0% -19.8% 93.53% -7.2% -82.05% 67.62% 103.88% -31.78% 88.09% -58.57% -17.65%

Expenses

Cost Of Revenues

Gross Profit

Gross Profit Margin

Gross Profit

Concept 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008
Revenue $0.00 $0.00 $0.00 $328.8K $410.0K $211.8K $228.3K $1.272M $758.7K $372.1K $545.5K $290.0K $700.0K $850.0K $0.00 $0.00
Cost Of Revenue $0.00 $17.60K $100.0K $133.3K $250.0K $818.6K $580.8K $469.1K $57.35K $440.0K $1.010M $390.0K
Gross Profit $0.00 $311.2K $310.0K $78.53K -$21.76K $453.1K $177.9K -$97.02K $488.1K -$150.0K -$310.0K $460.0K
Gross Profit Margin 94.65% 75.61% 37.07% -9.53% 35.63% 23.44% -26.07% 89.49% -51.72% -44.29% 54.12%

Selling, General & Admin Expense

Research & Development

Depreciation, Depletion & Amortization

SGA Expense to Gross Profit Ratio

R&D To Gross Profit Ratio

DDA To Gross Profit Ratio

Operating Expenses Total

Operating Profits/Loss

Operational Expenses

Concept 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008
Selling, General & Admin $4.428M $5.035M $5.734M $3.380M $2.050M $2.760M $2.940M $3.320M $3.230M $2.870M $1.770M $4.430M $3.610M $1.070M $70.00K $20.00K
YoY Change -12.06% -12.19% 69.65% 64.88% -25.72% -6.12% -11.45% 2.79% 12.54% 62.15% -60.05% 22.71% 237.38% 1428.57% 250.0%
% of Gross Profit 1086.12% 661.29% 3514.45% 732.69% 1815.98% 362.62% 232.61%
Research & Development $2.882M $4.795M $13.34M $17.95M $3.329M $1.100M $2.087M $1.973M $1.729M $1.029M $2.459M $2.019M $1.830M $830.0K $350.0K
YoY Change -39.89% -64.05% -25.7% 439.04% 202.68% -47.3% 5.78% 14.11% 67.99% -58.13% 21.82% 10.3% 120.48% 137.14%
% of Gross Profit 1069.88% 354.84% 2657.99% 381.67% 578.8% 413.54% 76.09%
Depreciation & Amortization $186.0K $4.328B $6.991B $8.323B $9.602B $0.00 $188.4K $179.3K $149.6K $159.5K $158.3K $124.8K $110.0K $90.00K $10.00K
YoY Change -100.0% -38.09% -16.0% -13.32% -100.0% 5.05% 19.9% -6.24% 0.76% 26.82% 13.48% 22.22% 800.0%
% of Gross Profit 3085475.58% 0.0% 239.86% 33.01% 89.69% 25.57% 2.17%
Operating Expenses $2.882M $4.795M $13.34M $17.95M $3.329M $3.140M $5.290M $5.453M $6.180M $5.097M $6.091M $4.393M $6.370M $4.520M $1.430M $70.00K $20.00K
YoY Change -39.89% -64.05% -25.7% 439.04% 6.03% -40.64% -2.98% -11.77% 21.24% -16.31% 38.63% -31.03% 40.93% 216.08% 1942.86% 250.0%
Operating Profit -$7.015M -$9.223M -$18.37M -$23.68M -$6.401M -$2.830M -$5.078M -$5.225M -$4.908M -$4.339M -$5.719M -$3.905M -$6.520M -$4.830M -$970.0K
YoY Change -23.94% -49.8% -22.43% 269.97% 126.18% -44.27% -2.8% 6.44% 13.13% -24.13% 46.43% -40.1% 34.99% 397.94%

Interest Expenses

Interest Expenses To Operating Income %

No data

Other Expense/Income

Interest & Other Expense/Income

Concept 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008
Interest Expense $268.1K $42.41K -$1.860K $40.00K $60.00K $40.00K $190.0K $100.0K -$600.0K -$160.0K -$90.00K $10.00K $1.240M $150.0K $0.00 $0.00
YoY Change 532.16% -2380.11% -104.65% -33.33% 50.0% -78.95% 90.0% -116.67% 275.0% 77.78% -1000.0% -99.19% 726.67%
% of Operating Profit
Other Income/Expense, Net $845.5K $849.1K $780.3K $10.34M $37.41K $40.10K $194.7K -$110.5K $1.532M -$2.694M -$10.65M $1.310M
YoY Change -0.43% 8.83% -92.45% 27535.47% -79.4% -276.16% -107.21% -156.88% -74.7% -912.75%

Income/Loss

Pretax Income

Income Tax

Net Profits/Loss

Pretax Income YoY Change

Income Tax Rate

No data

Net Profits/Loss YoY Change

Basic EPS

Net Income To Revenue Ratio

Pretax & Net Income

Concept 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008
Pretax Income -$6.169M -$8.374M -$17.55M -$13.34M -$6.363M -$2.780M -$4.307M -$4.540M -$4.001M -$3.258M -$4.183M -$2.082M -$5.200M -$3.600M -$590.0K -$60.00K -$20.00K
YoY Change -26.33% -52.28% 31.52% 109.67% 128.9% -35.45% -5.14% 13.47% 22.8% -22.11% 100.89% -59.95% 44.44% 510.17% 883.33% 200.0%
Income Tax $800.00 $800.00 $800.00 $800.00 $800.00 $800.00 $800.00 $7.200K $36.80K $27.20K $800.00 $0.00 $0.00 $0.00 $0.00 $0.00
% Of Pretax Income
Net Earnings -$6.200M -$8.374M -$17.55M -$13.34M -$6.360M -$2.780M -$5.039M -$5.031M -$5.026M -$2.843M -$8.440M -$14.50M -$5.200M -$3.600M -$590.0K -$60.00K -$20.00K
YoY Change -25.96% -52.28% 31.52% 109.8% 128.78% -44.83% 0.17% 0.09% 76.79% -66.31% -41.78% 178.76% 44.44% 510.17% 883.33% 200.0%
Net Earnings / Revenue -1934.3% -678.05% -2378.56% -2203.65% -395.23% -374.73% -2267.88% -2657.49% -1793.1% -514.29% -69.41%
Basic Earnings Per Share -$1.93 -$2.93 -$0.57 -$0.36 -$1.11 -$2.81
Diluted Earnings Per Share -$2.93 -$1.053M -$1.105M -$738.7K -$551.6K -$10.50M -$20.96M -$0.57 -$0.36 -$1.11 -$2.81 -$52.00M -$40.00M -$14.75M -$6.000M -$4.550M

Assets & Liabilities

Cash & Short-Term Investments

Cash & Equivalents

Cash To Operating Expenses Ratio

Inventory

Receivables

Total Short-Term Assets

Property, Plant And Equipment

Long-Term Investments

Total Long-Term Assets

Total Assets

Net Income To Total Assets Percentage

Accounts Payable

Short-Term Debt

Long Term Debt Due

Total Short-Term Liabilities

Long-Term Debt

Other Long-Term Liabilities

Total Long-Term Liabilities

Total Liabilities

Short-Term To Long-Term Debt Ratio

No data

Short-Term Assets To Debt Ratio

Long-Term Debt To Net Income Ratio

Assets & Liabilities

Concept 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008
Cash & Short-Term Investments $5.361M $7.091M $7.839M $7.210M $5.030M $10.30M $6.570M $11.41M $8.970M $13.89M $7.860M $1.000M $4.150M $2.000M $200.0K $50.00K
YoY Change -24.39% -9.55% 8.73% 43.34% -51.17% 56.77% -42.42% 27.2% -35.42% 76.72% 686.0% -75.9% 107.5% 900.0% 300.0%
Cash & Equivalents $5.361M $7.091M $7.839M $7.210M $5.030M $510.0K $4.570M $7.420M $3.960M $13.43M $7.860M $320.0K $920.0K $2.000M $200.0K $0.00
Short-Term Investments $6.080M $1.990M $3.990M $5.020M $460.0K $0.00
Other Short-Term Assets $448.9K $745.5K $948.7K $800.0K $400.0K $90.00K $120.0K $360.0K $180.0K $130.0K $90.00K $30.00K $40.00K $20.00K $0.00 $10.00K
YoY Change -39.79% -21.41% 18.58% 100.0% 344.44% -25.0% -66.67% 100.0% 38.46% 44.44% 200.0% -25.0% 100.0% -100.0%
Inventory $220.0K $70.00K $250.0K $560.0K
Prepaid Expenses
Receivables $626.5K $1.255M $3.303M $90.00K $220.0K $40.00K $0.00 $90.00K $160.0K $60.00K $20.00K $20.00K $40.00K $570.0K
Other Receivables $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $160.0K $0.00 $0.00 $0.00
Total Short-Term Assets $6.437M $9.092M $12.09M $8.100M $5.640M $10.66M $6.760M $12.10M $9.870M $14.07M $8.130M $1.050M $4.220M $2.590M $200.0K $50.00K
YoY Change -29.2% -24.8% 49.27% 43.62% -47.09% 57.69% -44.13% 22.59% -29.85% 73.06% 674.29% -75.12% 62.93% 1195.0% 300.0%
Property, Plant & Equipment $100.1K $31.16K $111.6K $170.0K $70.00K $1.060M $880.0K $760.0K $500.0K $390.0K $250.0K $330.0K $340.0K $90.00K
YoY Change 221.18% -72.07% -34.38% 142.86% -93.4% 20.45% 15.79% 52.0% 28.21% 56.0% -24.24% -2.94% 277.78%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $50.00K $70.00K $70.00K
YoY Change -28.57% 0.0%
Other Assets $173.5K $171.5K $20.00K $20.00K $20.00K $20.00K $20.00K $20.00K $20.00K $20.00K $10.00K $0.00 $30.00K
YoY Change 1.18% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 100.0% -100.0%
Total Long-Term Assets $2.454M $2.484M $2.494M $2.660M $80.00K $1.120M $960.0K $840.0K $520.0K $400.0K $380.0K $490.0K $530.0K $300.0K $0.00 $40.00K
YoY Change -1.22% -0.41% -6.24% 3225.0% -92.86% 16.67% 14.29% 61.54% 30.0% 5.26% -22.45% -7.55% 76.67% -100.0%
Total Assets $8.890M $11.58M $14.58M $10.76M $5.720M $11.78M $7.720M $12.94M $10.39M $14.47M $8.510M $1.540M $4.750M $2.890M $200.0K $90.00K
YoY Change
Accounts Payable $1.747M $2.122M $1.380M $1.460M $460.0K $490.0K $320.0K $620.0K $660.0K $530.0K $420.0K $430.0K $160.0K $420.0K $0.00 $10.00K
YoY Change -17.66% 53.77% -5.49% 217.39% -6.12% 53.13% -48.39% -6.06% 24.53% 26.19% -2.33% 168.75% -61.9% -100.0%
Accrued Expenses $74.71K $18.98K $78.81K $70.00K
YoY Change 293.62% -75.92% 12.59%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $1.822M $2.141M $1.459M $1.530M $460.0K $490.0K $320.0K $620.0K $2.380M $1.420M $3.870M $560.0K $160.0K $420.0K $0.00 $10.00K
YoY Change -14.9% 46.76% -4.66% 232.61% -6.12% 53.13% -48.39% -73.95% 67.61% -63.31% 591.07% 250.0% -61.9% -100.0%
Long-Term Debt $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $19.77K $43.66K $67.71K $120.0K $0.00 $5.350M $6.840M $130.0K $1.530M
YoY Change -54.72% -35.52% -43.58% -100.0% -21.78% 5161.54% -91.5%
Total Long-Term Liabilities $19.77K $43.66K $67.71K $120.0K $0.00 $0.00 $0.00 $0.00 $0.00 $5.350M $6.840M $130.0K $1.530M $0.00 $0.00 $0.00
YoY Change -54.72% -35.52% -43.58% -100.0% -21.78% 5161.54% -91.5%
Total Liabilities $1.842M $2.184M $1.526M $1.650M $460.0K $490.0K $320.0K $620.0K $2.380M $6.770M $10.71M $690.0K $1.690M $420.0K $0.00 $10.00K
YoY Change -15.69% 43.11% -7.49% 258.7% -6.12% 53.13% -48.39% -73.95% -64.84% -36.79% 1452.17% -59.17% 302.38% -100.0%

Ownership

Basic Shares Outstanding

Diluted Shares Outstanding

Preferred Stock

No data

Treasury Stock Shares

No data

Stock Issuance & Repurchase

Ownership Data

Concept 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008
Basic Shares Outstanding 3.197M 2.859M 8.826M shares 7.957M shares 7.583M shares 5.161M shares
Diluted Shares Outstanding 8.826M shares 7.957M shares 7.583M shares 5.161M shares
Preferred Stock
Treasury Stock Shares

Return On Shareholders' Equity

Book Value

Free Cash Flow

Free Cash Flow YoY

Free Cash Flow Margin

Dividends

Dividends

No data

Stock Price

Market Cap: $7.8912 Million

About Edesa Biotech, Inc.

Edesa Biotech, Inc. is a biopharmaceutical company, which focuses on acquiring, developing, and commercializing clinical stage drugs for inflammatory and immune-related diseases. The company is headquartered in Markham, Ontario and currently employs 16 full-time employees. The company went IPO on 2008-08-25. The firm's most advanced drug candidate is EB05 (paridiprubart), a monoclonal antibody developed for acute and chronic disease indications that involve dysregulated innate immune responses. The company is evaluating EB05 in a Phase III study as a potential treatment for acute respiratory distress syndrome, a life-threatening form of respiratory failure. EB05 has also been included in a United States government funded platform study of host directed therapeutics. The company has received Canadian regulatory approval to conduct a Phase II trial its EB06 (anti-CXCL10) monoclonal antibody as a treatment for vitiligo, a life-altering autoimmune disease that causes skin to lose its color in patches. The company is developing an sPLA2 inhibitor, EB01 (1.0% daniluromer cream), as a topical treatment for chronic Allergic Contact Dermatitis, a common occupational skin condition.

Industry: Pharmaceutical Preparations Peers: NYMOX PHARMACEUTICAL CORP Xenon Pharmaceuticals Inc.